
SID 26681509
CAS No. 958772-66-2
SID 26681509 ( —— )
产品货号. M26442 CAS No. 958772-66-2
SID 26681509 是一种选择性、可逆且竞争性的人组织蛋白酶 L 抑制剂(IC50 为 56 nM)。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1191 | 有现货 |
![]() ![]() |
10MG | ¥1847 | 有现货 |
![]() ![]() |
25MG | ¥3718 | 有现货 |
![]() ![]() |
50MG | ¥5565 | 有现货 |
![]() ![]() |
100MG | ¥7930 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称SID 26681509
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述SID 26681509 是一种选择性、可逆且竞争性的人组织蛋白酶 L 抑制剂(IC50 为 56 nM)。
-
产品描述SID 26681509 is a selective, reversible and competitive human cathepsin L inhibitor (IC50 of 56 nM).(In Vitro):After a 4 hr preincubation with cathepsin L, SID 26681509 becomes more potent(IC50 : 1.0 nM). SID 26681509 is determined to be a slow-binding and slowly reversible competitive inhibitor. Through a transient kinetic analysis for single-step reversibility, inhibition rate constants are kon = 24,000 M-1s-1 and koff = 2.2 × 10-5 s-1 (Ki = 0.89 nM). Molecular docking studies are undertaken using the experimentally-derived X-ray crystal structure of papain/CLIK-148. SID 26681509 inhibits papain and cathepsins B, K, S, and V with IC50 values determined after one hour ranging from 618 nM to 8.442 μM.(In Vivo):survival in murine models of sepsis significantly improved SID 26681509 by and reduces liver damage following warm liver ischemia/reperfusion (I/R) models.
-
体外实验After a 4 hr preincubation with cathepsin L, SID 26681509 becomes more potent, demonstrating an IC50 of 1.0 nM. SID 26681509 is determined to be a slow-binding and slowly reversible competitive inhibitor. Through a transient kinetic analysis for single-step reversibility, inhibition rate constants are kon = 24,000 M-1s-1 and koff = 2.2 × 10-5 s-1 (Ki = 0.89 nM). Molecular docking studies are undertaken using the experimentally-derived X-ray crystal structure of papain/CLIK-148. SID 26681509 inhibits papain and cathepsins B, K, S, and V with IC50 values determined after one hour ranging from 618 nM to 8.442 μM. SID 26681509 shows no inhibitory activity against the serine protease cathepsin G. SID 26681509 inhibits cathepsin V activity with an IC50 value of 0.5 μM. SID 26681509 (1-30 μM) blocks high-mobility group box 1 (HMGB1)-induced TNF-α production dose dependently without altering cell viability.
-
体内实验SID 26681509 treatment significantly improves survival in murine models of sepsis and reduces liver damage following warm liver ischemia/reperfusion (I/R) models.
-
同义词——
-
通路Proteasome/Ubiquitin
-
靶点Cysteine Protease
-
受体Hormone-sensitive lipase (HSL)
-
研究领域——
-
适应症——
化学信息
-
CAS Number958772-66-2
-
分子量539.65
-
分子式C27H33N5O5S
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 50 mg/mL (92.65 mM)
-
SMILESCCc1ccccc1NC(=O)CSC(=O)NNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Ebdrup, Soren, et al. PHARMACEUTICAL USE OF BORONIC ACIDS AND ESTERS THEREOF. US7037905.
产品手册




关联产品
-
Aureusimine B
Aureusimine B 是一种钙蛋白酶抑制剂,由金黄色葡萄球菌生物膜产生,可能是金黄色葡萄球菌生物膜感染的潜在生物标志物。
-
Liensinine Perchlora...
Liensinine 是莲子心的活性成分,具有抗高血压作用。
-
Dazcapistat
Dazcapistat 是一种有效的钙蛋白酶抑制剂,对于钙蛋白酶 1、钙蛋白酶 2 和钙蛋白酶 9 的 IC50 分别 <3 μM。